The Defense Logistics Agency (DLA) awarded a $8,452.35 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide YF-VAX 1 dose vials. This contract is part of DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. This specific delivery order does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure the award. The contract has an ultimate completion date of January 10, 2025.
Generated 3/19/25, 9:44 AM